A Search Service for Abbreviation / Long Form

â–  Abbreviation / Long Form : BRC / breast cancer

[Related PubMed/MEDLINE]
Total Number of Papers: 32
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   BRC  (>> Co-occurring Abbreviation)
Long Form:   breast cancer
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Genomic Signature of the Standardized Uptake Value in 18F-Fluorodeoxyglucose Positron Emission Tomography in Breast Cancer. CI, FDG-PET, HR, SUV
2020 Rad51 paralogs and the risk of unselected breast cancer: A case-control study. SNPs
2019 A Case-Control Study of the Association Between the SPP1 Gene SNPs and the Susceptibility to Breast Cancer in Guangxi, China. OR, SPP1
2019 Frequency of Epstein–Barr Virus DNA in Formalin-Fixed Paraffin-Embedded Tissue of Patients with Ductal Breast Carcinoma ---
2019 Knockdown of FAM64A suppresses proliferation and migration of breast cancer cells. ---
2019 Late urinary bladder metastasis from breast cancer. TURB-T
2019 N6-methyladenosine-related Genomic Targets are Altered in Breast Cancer Tissue and Associated with Poor Survival. GEO, HPA, IF, IHC, m6A, OS, TMA
2019 Overexpression of circulating MiR-30b-5p identifies advanced breast cancer. ---
2019 Predictive and Prognostic Value of Selected MicroRNAs in Luminal Breast Cancer. ---
10  2019 Risk of loco-regional recurrence and distant metastases of patients with invasive breast cancer up to ten years after diagnosis - results from a registry-based study from Germany. CI
11  2019 Selectively hampered activation of lymph node-resident dendritic cells precedes profound T cell suppression and metastatic spread in the breast cancer sentinel lymph node. DC, LNR, SLN
12  2019 SETDB1 regulates SMAD7 expression for breast cancer metastasis. GO, SETDB1
13  2019 The novel prognostic marker, EHMT2, is involved in cell proliferation via HSPD1 regulation in breast cancer. EHMT2, HER2
14  2018 A DNA Methylation-Based Test for Breast Cancer Detection in Circulating Cell-Free DNA. ccfDNA, qMSP, ROC
15  2018 Analyzing the Communication Between Monocytes and Primary Breast Cancer Cells in an Extracellular Matrix Extract (ECME)-based Three-dimensional System. ECM, ECME, G-CSF, IL, MCP-1, MMP, RANTES, TAMs
16  2018 Bladder Metastases from Breast Cancer: Managing the Unexpected. A Systematic Review. ---
17  2018 Elevated plasma levels of tissue factor as a valuable diagnostic biomarker with relevant efficacy for prediction of breast cancer morbidity. ELISA, ROC, TF, VEGF-A
18  2017 Differential expression of VEGFR2 protein in HER2 positive primary human breast cancer: potential relevance to anti-angiogenic therapies. TNBCs
19  2017 Evidence of lateral transmission of aggressive features between different types of breast cancer cells. ---
20  2017 Guided web-based intervention for insomnia targeting breast cancer patients: Feasibility and effect. I-CBT, I-Sleep
21  2017 Optical Screening of Female Breast Cancer from Whole Blood Using Raman Spectroscopy. PLS, ROC
22  2014 Genetic polymorphisms in the 9p21 region associated with risk of multiple cancers. BC, ESCC, GC, GWAS, LC, PrC, RCC, SNPs
23  2014 Infiltrating S100A8+ myeloid cells promote metastatic spread of human breast cancer and predict poor clinical outcome. MDSCs, MIF
24  2014 Low-mass-ion discriminant equation: a new concept for colorectal cancer screening. CRC, FOBT, GC, LMIs, LOME, MS
25  2014 Provision of breast cancer care and survival in Germany - results from a population-based high resolution study from Saarland. CPG, RER, RS, SND
26  2014 Single nucleotide polymorphisms in noncoding regions of Rad51C do not change the risk of unselected breast cancer but they modulate the level of oxidative stress and the DNA damage characteristics: a case-control study. SNPs
27  2011 Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer. CAM, CRC, miRNAs, NSCLC
28  2010 Single nucleotide variation in exon 11 of canine BRCA2 in healthy and cancerous mammary tissue. SNP
29  2006 HER-2/neu genotype of breast cancer may change in bone metastasis. ---
30  2005 Microvascular density of breast cancer in bone metastasis: influence of therapy. MVD, VEGF
31  2000 Patients with double primary tumors in the breast and ovary- clinical characteristics and BRCA1-2 mutations status. OVC, PPMBr
32  1989 Plasma glutamate--a prognostic marker of cancer and of other immunodeficiency syndromes? CRC, Glu, HIV, IDS